G6PD deficiency in malaria endemic areas of Nepal
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is currently a threat to malaria elimination due to risk of primaquine-induced haemolysis in G6PD deficient individuals. The World Health Organization (WHO) recommends G6PD screening before providing primaquine as a radical treatment against vivax...
Saved in:
Published in | Malaria journal Vol. 19; no. 1; p. 287 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
12.08.2020
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!